SOBKY - Tempus wins FDA nod for AI-backed heart diagnostic
2024-06-26 10:09:12 ET
More on Tempus AI, Inc
- Tempus AI: Healthcare AI Play Faces Some Challenges From The Start
- Spotlight On Apple's AI Strategy, The Fed Meeting, And Latest CPI Print
- Tempus AI's High Stakes IPO: A Gamble On Growth Amid Soaring Losses
- IPO roundup: Lionheart Holdings, Melar Acquisition Corp. I, and more
- Tempus AI stock jumps 14% following $411M IPO